Fed Meeting This Week. We are preparing a report on a tiny float, recent IPO NASDAQ that just entered oversold territory. To be issued Monday 12-13-21 near market open.

Fed Meeting This Week

We are preparing a report on a tiny float, recent IPO NASDAQ that just entered oversold territory. To be issued Monday 12-13-21 near market open.

Good day everyone,

The markets are making a comeback with the DJIA closing at 35,970 on Friday and the NASDAQ at 15,360. My Coinbase account is hurting a bit right now though.

The Labor Department’s Consumer Price Index climbed by 6.8% in November compared to last year, I still believe the inflation rate will tamp down in 1H22. I want to remind you, once again, that the FED is meeting this coming Tuesday-Wednesday, the 14th & 15th. I don’t expect any surprises to come out of that meeting but there always seems to be some market response to Fed meetings.

Covid is causing changes in our healthcare system as the virus has exposed the strengths and weaknesses in the way humans are cared for. Hospitals have been stretched to capacity (and beyond at times), physicians have introduced virus control measures at their offices and clinics, and the biopharma industry is scrambling to produce new products to combat the pandemic.

Human history indicates that our most costly battles, in terms of human life, are our battles with viruses and infections, from Bubonic Plague to Spanish Flu, and now Coronavirus with its never-ending variants. All these human tragedies have one thing in common, we were unprepared for them.

We want to report on a NASDAQ company involved with healthcare. One whose mission is to help the healthcare system transform through technology. Today, we have technological weapons to deploy in the battle for survival against insidious viruses and infections. Technology can help us develop drugs faster, make hospitals more efficient and create virtual treatments from physicians.

This company I want to talk about has the tools available to help create some of those changes. Like many of the companies we report on, this one has a tiny float, impressive revenues, high insider ownership, and is trading significantly off their recent high price.

Stay tuned and stay informed.

The Traders News Group